The Full Library
Archive

The Full Library

Every article, guide, and research update — all in one place.

1 articles published
Back to Hub
dual agonist
7 min read

Tirzepatide vs Semaglutide: ACP's 2026 Weight Loss Guidance

The ACP's 2026 guidelines place tirzepatide and semaglutide as first-line obesity treatments. This article examines their mechanisms, metabolic effects, and clinical differences.

Read Now